BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Diagnosis
10 results:

  • 1. Oncocytoid Salivary Tumors: Differential diagnosis and Utility of Newly Described Immunohistochemistry.
    Katabi N
    Head Neck Pathol; 2024 Mar; 18(1):20. PubMed ID: 38502259
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Correlation of ntrk1 Downregulation with Low Levels of Tumor-Infiltrating Immune Cells and Poor Prognosis of prostate cancer Revealed by Gene Network Analysis.
    Bagherabadi A; Hooshmand A; Shekari N; Singh P; Zolghadri S; Stanek A; Dohare R
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627227
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adult Ntrk-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
    Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
    Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
    Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
    BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel PTPRZ1-ETV1 fusion in gliomas.
    Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D
    Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Predictors of Response Outcomes for Research Recruitment Through a Central cancer Registry: Evidence From 17 Recruitment Efforts for Population-Based Studies.
    Millar MM; Kinney AY; Camp NJ; Cannon-Albright LA; Hashibe M; Penson DF; Kirchhoff AC; Neklason DW; Gilsenan AW; Dieck GS; Stroup AM; Edwards SL; Bateman C; Carter ME; Sweeney C
    Am J Epidemiol; 2019 May; 188(5):928-939. PubMed ID: 30689685
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Expressions of neurotrophic factors and their receptors in prostate cancer].
    Liu M; Su YH; Chen Y
    Zhonghua Nan Ke Xue; 2010 Feb; 16(2):129-31. PubMed ID: 20369695
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A possible role of BDNF in prostate cancer detection.
    Bronzetti E; Artico M; Forte F; Pagliarella G; Felici LM; D'Ambrosio A; Vespasiani G; Bronzetti B
    Oncol Rep; 2008 Apr; 19(4):969-74. PubMed ID: 18357383
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [The progress in diagnostic imaging for staging of bladder and prostate cancer: endorectal magnetic resonance imaging and magnetization transfer contrast].
    Arima K; Hayashi N; Yanagawa M; Kawamura J; Kobayashi S; Takeda K; Sugimura Y
    Hinyokika Kiyo; 1999 Aug; 45(8):553-7. PubMed ID: 10500962
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.